Physician profile
Taylor Gregory Trace
NPI 1225689599
$15,068.93
in general payments reported to CMS, 2019-2025
52 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,009 · 2022: $2,804 · 2023: $2,522 · 2024: $2,336 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,256.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,562.59 | 2021-2025 | |
| Novo Nordisk INC | $2,008.30 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,626.20 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,134.57 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $948.74 | 2021-2025 | Repatha, Otezla, Prolia |
| Pfizer INC. | $909.81 | 2021-2025 | |
| Lilly USA, LLC | $843.26 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $542.44 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Bayer Healthcare Pharmaceuticals INC. | $411.72 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $381.78 | 2021-2024 | Xifaxan |
| Exact Sciences Corporation | $328.60 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $286.27 | 2021-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.96 | 2021-2024 | Jardiance, Tradjenta, Synjardy |
| Biohaven Pharmaceuticals, INC. | $233.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $230.58 | 2021-2024 | Rexulti |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Trace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.